Pnc Financial Services Group, Inc. Amgen Inc Transaction History

Pnc Financial Services Group, Inc.

$150 Billion
Q2 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,068,066 shares of AMGN stock, worth $338 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,068,066

Previous 1,081,289 1.22%

Holding current value

$338 Million

Previous $307 Million 8.55%

% of portfolio

0.22%

Previous 0.21%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $3.47 Million - $4.22 Million	-13,223 Reduced 1.22%	1,068,066 $334 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $5.51 Million - $6.65 Million	-20,491 Reduced 1.86%	1,081,289 $307 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $2.83 Million - $3.19 Million	11,067 Added 1.01%	1,101,780 $317 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $9.2 Million - $11.4 Million	42,092 Added 4.01%	1,090,713 $293 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $13.6 Million - $16.1 Million	-63,466 Reduced 5.71%	1,048,621 $233 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $5.86 Million - $7.14 Million	-25,960 Reduced 2.28%	1,112,087 $269 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $4.13 Million - $5.25 Million	-18,045 Reduced 1.56%	1,138,047 $299 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $4.12 Million - $4.65 Million	-18,371 Reduced 1.56%	1,156,092 $261 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $1.86 Million - $2.07 Million	-8,062 Reduced 0.68%	1,174,463 $286 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $6.21 Million - $6.87 Million	-28,309 Reduced 2.34%	1,182,525 $286 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $52.1 Million - $59.7 Million	-262,173 Reduced 17.8%	1,210,834 $272 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $18.7 Million - $21.9 Million	-88,030 Reduced 5.64%	1,473,007 $313 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $3.33 Million - $3.7 Million	-14,264 Reduced 0.91%	1,561,037 $381 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $17.5 Million - $20.4 Million	-78,955 Reduced 4.77%	1,575,301 $392 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $11.9 Million - $14.1 Million	-54,801 Reduced 3.21%	1,654,256 $380 Million
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $623,230 - $693,083	2,656 Added 0.16%	1,709,057 $434 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $5 Million - $6.14 Million	-25,278 Reduced 1.46%	1,706,401 $402 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $25.5 Million - $33.9 Million	-140,186 Reduced 7.49%	1,731,679 $351 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $3.98 Million - $5.11 Million	-21,021 Reduced 1.11%	1,871,865 $451 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $7.91 Million - $9.48 Million	-45,435 Reduced 2.34%	1,892,886 $366 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $8.48 Million - $9.94 Million	-50,853 Reduced 2.56%	1,938,321 $0
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $11.9 Million - $13.5 Million	-66,017 Reduced 3.21%	1,989,174 $0
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $11.3 Million - $13.2 Million	-63,219 Reduced 2.98%	2,055,191 $400 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $452,663 - $510,318	-2,443 Reduced 0.12%	2,118,410 $0
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $1.08 Million - $1.21 Million	-6,484 Reduced 0.3%	2,120,853 $0
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $1.92 Million - $2.24 Million	11,327 Added 0.54%	2,127,337 $0
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $1.07 Million - $1.2 Million	-6,342 Reduced 0.3%	2,116,010 $0
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $355 Million - $405 Million	2,122,352	2,122,352 $0

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Amgen Inc Transaction History